- Conditions
- Ulcerative Colitis
- Interventions
- IMU-838, Placebo
- Drug
- Lead sponsor
- Immunic AG
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 263 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 15
- States / cities
- Tucson, Arizona • Los Angeles, California • Ventura, California + 12 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Multiple Sclerosis
- Interventions
- IMU-838 tablets, Placebo matching IMU-838 tablets
- Drug
- Lead sponsor
- Immunic AG
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 1,121 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2033
- U.S. locations
- 6
- States / cities
- Phoenix, Arizona • West Hollywood, California • Bradenton, Florida + 3 more
- Conditions
- Multiple Sclerosis, Relapsing-Remitting
- Interventions
- IMU-838 tablets, Placebo matching IMU-838 tablets
- Drug
- Lead sponsor
- Immunic AG
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 1,100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2033
- U.S. locations
- 2
- States / cities
- Altamonte Springs, Florida • Coral Springs, Florida
- Conditions
- Multiple Sclerosis
- Interventions
- IMU-838, Placebo matching IMU-838
- Drug
- Lead sponsor
- Immunic AG
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 450 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 8
- States / cities
- Coral Springs, Florida • Naples, Florida • Ormond Beach, Florida + 5 more
- Conditions
- Primary Sclerosing Cholangitis
- Interventions
- Vidofludimus calcium
- Drug
- Lead sponsor
- Elizabeth Carey
- Other
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 3
- States / cities
- Phoenix, Arizona • Tempe, Arizona • Rochester, Minnesota